Patient Registry Software Market by Delivery Mode (Subscription, Ownership), Functionality (Population Health Management, Point of Care, Care Management), Database (Diabetes, Cancer, Cardiovascular, Chronic & Rare Disease) & by End User - Forecast to 2019

The patient registry software market is expected to reach $610.8 million by 2019 from $381.0 million in 2014, at a CAGR of 9.9%. The global patient registry software market is categorized on the basis of delivery model, product type, database type, functionality, end user, and region. The subscription models segment is expected to register the highest growth rate in the patient registry software market, by delivery model, during the forecast period. Its favorable growth is attributed to the various advantages offered by this model—data centralization capabilities, automatic software upgradation, and easy customization. Furthermore, the subscription model offers cost-effectiveness due to the elimination of purchasing costs of software and hardware.

Major factors contributing to growth of the patient registry software market include increasing pressure on healthcare organizations to improve the quality of care and minimize healthcare costs, and the increasing adoption of EHRs. Various initiatives are being taken by governments across the globe for enhancing population health management, which is another major factor providing an impetus to the growth of this market. For instance, in August 2013, Germany launched an Open-Source Registry System (OSSE) project, funded by the Federal Ministry of Health, for Rare Diseases in the EU as part of the National Plan for Rare Diseases (RD). The increasing focus on rare disease registries and the high adoption rate of subscription models has opened an array of opportunities for the patient registry software market.

However, data privacy & security concerns, lack of resources with cross-functional skills, and reluctance towards adopting new advanced systems are expected to restrain the growth of this market.

Subscription models, integrated patient registry software, and rare diseases registries are expected to serve as new revenue pockets for the patient registry software market in the coming five years.

Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the patient registry software market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms gain a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on the product portfolios of top players in the patient registry software market. The report analyzes the patient registry software market by delivery model, product type, database type, functionality, end user, and region
‧ Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the patient registry software market
‧ Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the patient registry software market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various patient registry software products across regions
‧ Market Diversification: Exhaustive information about new products and services, untapped regions, recent developments, and investments in the patient registry software market

Table of Contents

1 Introduction (Page No. - 10)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. - 14)
2.1 Market Size Estimation
2.2 Market Breakdown & Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Key Data From Primary Resources
2.6 Assumptions

3 Executive Summary (Page No. - 21)

4 Premium Insights (Page No. - 26)
4.1 Patient Registry Software Market, By Delivery Model
4.2 Patient Registry Software Market, By End User
4.3 Patient Registry Software Market, By Functionality
4.4 Geographic Snapshot
4.5 Patient Registry Software Market, By Product Type
4.6 Patient Registry Software Market, By Database Type
4.7 Patient Registries Software Market, By Delivery Model

5 Market Overview (Page No. - 31)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Patient Registry Software Market, By Delivery Model
5.2.2 Patient Registry Software Market, By Product Type
5.2.3 Patient Registry Software Market, By Database Type
5.2.4 Patient Registry Software Market, By Functionality
5.2.5 Patient Registry Software Market, By End User
5.2.6 Patient Registry Software Market, By Region
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Government Initiatives to Build Patient Registries
5.3.1.2 Increasing Pressure to Improve Quality of Care and Minimize Healthcare Costs
5.3.1.3 Increasing Adoption of EHRs
5.3.1.4 Rising Number of Accountable Care Organizations (ACOS)
5.3.2 Restraints
5.3.2.1 Data Privacy & Security Concerns
5.3.2.2 Lack of Resources With Cross-Functional Skills
5.3.3 Opportunities
5.3.3.1 Subscription Model Presents High Growth Potential
5.3.3.2 Shifting Focus Towards Patient-Powered Research Network (PPRN)
5.3.4 Challenges
5.3.4.1 Interoperability
5.3.4.2 Reluctance Towards Adopting New Advanced Systems

6 Industry Insights (Page No. - 41)
6.1 Porter’s Five Forces Analysis
6.1.1 Threat From New Entrants
6.1.2 Bargaining Power of Suppliers
6.1.3 Bargaining Power of Buyers
6.1.4 Threat From Substitutes
6.1.5 Intensity of Competitive Rivalry
6.2 Pest Analysis
6.2.1 Political Factors
6.2.2 Economic Factors
6.2.3 Social Factors
6.2.4 Technological Factors
6.3 Strategic Benchmarking

7 Patient Registry Software Market, By Delivery Model (Page No. - 46)
7.2 Introduction
7.3 Subscription Models
7.4 Ownership Models

8 Patient Registry Software Market, By Product Type (Page No. - 52)
8.1 Introduction
8.2 Standalone Software
8.3 Integrated Software

9 Patient Registry Software Market, By Database Type (Page No. - 56)
9.1 Introduction
9.2 Diabetes Registries
9.3 Cardiovascular Registries
9.4 Cancer Registries
9.5 Rare Disease Registries
9.6 Chronic Disease Registries
9.7 Other Registries

10 Patient Registry Software Market, By Functionality (Page No. - 67)
10.1 Introduction
10.2 Population Health Management (PHM)
10.3 Patient Care Management
10.4 Point of Care
10.5 Product Outcome Evaluation

11 Patient Registry Software Market, By End User (Page No. - 74)
11.1 Introduction
11.2 Government Organizations & Tpas (Third-Party Administrators)
11.3 Hospitals & Medical Practices
11.4 Private Payers
11.5 Pharmaceutical & Medical Device Companies

12 Patient Registry Software Market, By Region (Page No. - 82)
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.3 Europe
12.4 Asia-Pacific (APAC)
12.5 Rest of the World (ROW)

13 Competitive Landscape (Page No. - 105)
13.1 Overview
13.2 Competitive Situation and Trends
13.2.1 Partnerships and Collaborations
13.2.2 Product & Service Enhancements
13.2.3 Expansions
13.2.4 Acquisitions

14 Company Profiles (Page No. - 111)
14.1 Imagetrend, Inc.
14.1.1 Business Overview
14.1.2 Product Portfolio
14.1.3 Key Strategy
14.1.4 Recent Developments
14.1.5 MNM View
14.2 Inc Research Holdings, Inc.
14.2.1 Business Overview
14.2.2 Product Portfolio
14.2.3 Key Strategy
14.2.4 Recent Development
14.2.5 MNM View
14.3 Phytel, Inc.
14.3.1 Business Overview
14.3.2 Product Portfolio
14.3.3 Key Strategy
14.3.4 Recent Developments
14.3.5 MNM View
14.4 Quintiles Transnational Holdings, Inc.
14.4.1 Business Overview
14.4.2 Product Portfolio
14.4.3 Key Strategy
14.4.4 Recent Development
14.4.5 MNM View
14.5 Velos, Inc.
14.5.1 Business Overview
14.5.2 Product Portfolio
14.5.3 Key Strategy
14.5.4 Recent Development
14.6 Global Vision Technologies, Inc.
14.6.1 Business Overview
14.6.2 Product Portfolio
14.6.3 Key Strategy
14.6.4 Recent Developments
14.7 IFA Systems AG
14.7.1 Business Overview
14.7.2 Product Portfolio
14.7.3 Key Strategy
14.8 Mckesson Corporation
14.8.1 Business Overview
14.8.2 Product Portfolio
14.8.3 Key Strategy
14.8.4 Recent Development
14.9 Optum, Inc. (A Part of Unitedhealth Group, Inc.)
14.9.1 Business Overview
14.9.2 Product Portfolio
14.9.3 Key Strategy
14.10 Telligen, Inc.
14.10.1 Business Overview
14.10.2 Product Portfolio
14.10.3 Key Strategy
14.10.4 Recent Development

15 Appendix (Page No. - 129)
15.1 Insights From Industry Experts
15.2 Discussion Guide
15.3 Introducing RT: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports